.jpg)
In this episode, our specialist in the lab equipment space, Lucy Smith, spoke with CEO of Elementar Americas Ryan Titmas. Lucy spoke to Ryan about what it takes to get to the top, as well as some of the lessons he’s learned in his career so far.
Even if you’ve been through the process, you may not be aware of exactly what goes into M&A deals. Today, we’ve tried to look into that in a little more detail with Transaction Liability Team Leader Grant Hollis from CFC Underwriting,
One of the biggest partnering events in the life science calendar Bio-Europe Spring, was scheduled to take place in Paris from March 23 – 27 this year. That all changed with the emergence of COVID-19...
There’s so much more to the UK biotech scene than just London and Cambridge. In the North, we're surrounded by many fascinating companies who’re innovating and conducting crucial research.
It's humbling to see how the life science community has come together to combat the coronavirus. Here's what's happening in diagnostics.
Innovative and pioneering, Synthego, a provider of synthetic RNA solutions for CRISPR Genome Engineering, are looking to grow their team.
Reported to correct 89% of pathogenic human gene variants, prime gene editing has the potential to target over 75,000 different mutations in treatment.
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
In November this year, as first broken by the MIT Technology Review, it was revealed that Chinese scientist He Jiankui had been conducting gene-editing research using CRISPR technology on foetuses as late as 24 weeks into pregnancy.
Until very recently, the most talked about and desirable technology within molecular biology was Next Generation Sequencing (NGS). NGS was the technology sales reps wanted to sell and molecular biologists wanted to work with. Recently though,...
